Mianserin: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness

@article{Brogden2012MianserinAR,
  title={Mianserin: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness},
  author={R. Brogden and R. Heel and T. Speight and G. S. Avery},
  journal={Drugs},
  year={2012},
  volume={16},
  pages={273-301}
}
  • R. Brogden, R. Heel, +1 author G. S. Avery
  • Published 2012
  • Medicine
  • Drugs
  • SummarySynopsis: Mianserin1 is a tetracyclic compound advocated for the treatment of depressive illness and depression associated with anxiety. It combines antidepressant activity with a sedative effect and has an EEG and clinical activity profile similar to that of amitriptyline. It has an overall efficacy comparable with amitriptyline and imipramine in depressive illness, but at dosages which have achieved a similar overall clinical improvement, mianserin causes significantly fewer… CONTINUE READING
    311 Citations
    The cardiovascular effects of antidepressants.
    • 70
    Serum mianserin and ageing
    • 10
    Current Antidepressant Drugs: Their Clinical Use
    • 10
    Biochemical investigations into the mode of action of trazodone
    • 62
    Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs
    • K. Ikeguchi, A. Kuroda
    • Psychology, Medicine
    • European Archives of Psychiatry and Clinical Neuroscience
    • 2005
    • 42
    Lack of anticholinergic and cardiovascular effects of mianserin; studies in healthy subjects and heart patients
    • H. Kopera
    • Medicine
    • Acta psychiatrica Scandinavica. Supplementum
    • 1983
    • 15
    Chapter 1 Antidepressants
    • 6

    References

    SHOWING 1-10 OF 219 REFERENCES
    Mianserin: a decade of scientific development.
    • 38
    Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    • 39
    A clinical trial with nomifensin, a new antidepressant drug.
    • 6
    Effect of zimelidine (H 102/09) in depressive patients.
    • 21